Novel risk model for predicting incident atrial fibrillation in patients at high cardiovascular risk receiving omega-3 fatty acid: sub-analysis from the STRENGTH randomized clinical trial

29 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Lipids: drug therapy Drug therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo

Cleveland Clinic, Cleveland (United States of America)

4 More presentations in this session

Presentation thumbnail
Doctor C. Soh (Melbourne, AU)
Presentation thumbnail
Professor L. Rallidis (Athens, GR)
Presentation thumbnail
Doctor M. Bellomare (Milan, IT)

The Event

Event poster

ESC Congress 2025

29 August 2025 12:30 CET

ESC 365 is supported by

ESC 365 is supported by